CytoCan Corp.

CytoCan - A Platform for Biologics with Multispecificity Targeted IO Therapy.

We are a team dedicated to turning hope into medicine and accelerating First-in-Class innovation!


A novel platform technology to produce cancer cell-targeting immunotherapeutic proteins with multispecificity.


CytoCan is devoted to develop life-changing multispecific proteins to help patients fight cancer. We envision a near future where cancer is a controllable disease. Patient can live with cancer with no fear.


A novel modular platform technology to produce cancer cell-targeting proteins with multispecific functions. By targeting immune cytokines precisely to cancer cells, our fusion proteins help reduce the risk of unintended systemic side effects.


AbZed: A revolutionary humanized IgG binding domain serving as the critical connector for functional modules.


By identifying the unmet medical needs and difficult-to-treat cancers, we design targeted immune therapies to better help patients. By targeting therapies to cancer cells, the new class of therapies reduce systemic and unintended side effects.


Find Out More About Us

CytoCan is a biopharmaceutical company focusing on creating multispecific fusion proteins with a modular platform called AbZed.

Building a LEGO platform for multispecific biologics

CytoCan is devoted to creating First-in-Class medicines to bring benefit to patients. As a modular platform, the AbZed fusion proteins contain three modules: affinity, connector, and cytokine modules. By switching to new antibody fragments or ligands, we can create therapeutic proteins for a new cancer targets. The cytokine module can also be replaced with an affinity module to develop a bi-specific antibody-like protein.

In the News

Press Release - CytoCan received seed round investment


Check our Pipeline

Our Pipeline includes the next generation multispecific HER2, EGFR and TROP targeted therapies.

Pipeline Early Discovery Preclinical IND Enabling Phase I Clinical Trial Indications
CC-001 HER2_AbZed
breast cancer, gastric cancer
CC-002 EGFR_AbZed
head & neck cancer, colorectal cancer
CC-003 Trop-2_AbZed
breast cancer


Contact Us

Feel free to contact us by mail, email or phone with your inquiry.

Our Hangzhou office:

A-603-1 Huarun Plaza, 1366 Qianjiang Road
Shangcheng District Hangzhou City, Zhejiang China

Email Us

Call Us


Your message has been sent. Thank you!